Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-1 Capsule for Influenza-Related Fever (Phase II)
CTR20192482Phase 2Completed
- Sponsor
- Guangdong Lane Pharmaceutical Research Institute
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of forsythin in influenza, nasopharyngitis, sponsored by Guangdong Lane Pharmaceutical Research Institute. Started Nov 2019; status: completed.
02
Drugs
forsythin
03
Conditions
influenzanasopharyngitis
Beyond the preview
Go deeper on CTR20192482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192482.